The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Open accessAbstract
Adults with Down syndrome develop the neuropathological hallmarks of Alzheimer's disease and are at very high risk of developing early-onset dementia, which is now the leading cause of death in this population. Diagnosis of dementia remains a clinical challenge because of the lack of validated diagnostic criteria in this population, and because symptoms are overshadowed by the intellectual disability associated with Down syndrome. In people with Down syndrome, fluid and imaging biomarkers have shown good diagnostic performances and a strikingly similar temporality of changes with respect to sporadic and autosomal dominant Alzheimer's disease. Most importantly, there are no treatments to prevent Alzheimer's disease, even though adults with Down syndrome could be an optimal population in whom to conduct Alzheimer's disease prevention trials. Unprecedented research activity in Down syndrome is rapidly changing this bleak scenario that will translate into disease-modifying therapies that could benefit other populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that the brain changes of Alzheimer's disease in people with Down syndrome are more common than these percentages indicate.92,93”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Emerging research suggests that Alzheimer's brain changes in people with Down syndrome may be even more common than these percentages indicate.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [100]
The cited source says what the claim attributes to it.
In the citing paper
“increased risk for early‐onset Alzheimer's disease (AD). 2”
The cited source says what the claim attributes to it.
In the citing paper
“Although the extra copy of the amyloid precursor protein (APP) gene increases the penetrance of AD in DS, 2 , 6”
The cited source says what the claim attributes to it.
In the citing paper
“By age 40 years, most individuals with DS will have developed Alzheimer’s disease (AD) pathology, characterised by the accumulation of amyloid-β plaques and neurofibrillary tau tangles (NFT) within the brain [17, 69].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [17]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This relationship is observed across the AD continuum, including the asymptomatic phase in sporadic and genetic forms of AD.11,12,13,14”
From Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology (2024) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484
Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
Research works printed but not linked: 1
- Blesa, 2015, Alzheimer's disease in adults with Down syndrome: a challenge, T21 Res Sci Soc Bull, 2, 4
Cited by
Sorted by citations
Items 201–300 of 365
Factors Associated With Alzheimer's Dementia Diagnosis and Survival in Down Syndrome
Pounds, O., Theodore, K., & Dodd, K. (2025) · Journal of Intellectual Disability Research · doi:10.1111/jir.13230 · Cited by 3
Munn, E. E., Montelongo, A., Patel, V. K., Fodstad, J. C., Ciccarelli, M. R., Ptomey, L. T., & Pangelinan, M. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70471 · Cited by 2
Aging Unequally: Functional Age Disparities Between Developmental and Non-Developmental Disabilities
Jeong, J. U. (2025) · Healthcare · doi:10.3390/healthcare13192412 · Cited by 3
Ocampo, K. E., Fernandez, Y. C., Magaña‐Ordorica, D., Angulo‐Rojo, C., Guadrón‐Llanos, A. M., Castro-Apodaca, F. J., & Magaña‐Gómez, J. A. (2022) · REVMEDUAS · doi:10.28960/revmeduas.2007-8013.v12.se.002 · Cited by 5
Cognitive Impairment in the Primary Care Clinic
Womack, C. L., Perkins, A., & Arnold, J. M. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.02.010 · Cited by 3
A pathway linking pulse pressure to dementia in adults with Down syndrome
Rizvi, B. M., Lao, P. J., Sathishkumar, M. T., Taylor, L., Queder, N., McMillan, L. C., Edwards, N. C., Keator, D. B., Doran, E. W., Hom, C. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae157 · Cited by 3
Self-citationComparing research attitudes in Down syndrome and non‐Down syndrome research decision‐makers
Lu, T. V. D., Campos, P., Leader, S., Lee, X., Xu, H., Doran, E. W., Grill, J. D., & Lott, I. T. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12478 · Cited by 3
Long term rescue of Alzheimer’s deficits in vivo by one-time gene-editing of App C-terminusPreprint
Aulston, B. D., Gimse, K., Bazick, H., Kramár, E. A., Pizzo, D. P., Shavarebi, F., Rust, T., Rosa, S. G., Parra‐Rivas, L. A., Sun, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.08.598099 · Cited by 4
Rao, N. R., DeGulis, O. A., Nomura, T., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E. X., Dulewicz, M., Ge, J., Upadhyay, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620698 · Cited by 3
Aguilar, L. F., Hamlett, E. D., Araya, P., Barone, E., Bhattacharyya, A., Carmona‐Iragui, M., Chan, L. F., Christian, B. T., Costa, A. C. S., Costanzo, F., et al. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08824-y · Cited by 2
Self-citationGarcía‐Alba, J., Molanes‐López, E. M., Zuluaga, P., Fenellós, C. B., Vaquero, L., Alfayate, E., García, F., Mateo, G., Modenhauer, F., Galván‐Román, J. M., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70084 · Cited by 2
Reversing intellectual disabilities in Down syndrome: Hopes or hypes?
Lim, C. T., Lim, C. W., Cheah, P.-S., & Ling, K. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_646_2025 · Cited by 2
Barros‐Santos, B., Campos‐Marques, C., Salvador, A. F., & Silva, J. M. (2025) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2025.04.006 · Cited by 2
Adults with down syndrome exhibit altered somatosensory cortical inhibition
Meejang, J., Busboom, M. T., Baker, S. E., Arif, Y., Kastner, O., Wilson, T. W., & Kurz, M. J. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103797 · Cited by 2
The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathology
Cuello, A. C., & Carmo, S. D. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00010-x · Cited by 2
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease
Fleming, V., Peven, J. C., Helsel, B. C., Ptomey, L. T., Clina, J. G., Barry, A., Ances, B. M., Handen, B. L., Christian, B. T., Laymon, C. M., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70127 · Cited by 2
Self-citationMantovani, D. B. D. A., Oliveira, L. C., Spelta, L. E. W., Carvalho, C. L., Forlenza, O. V., Marie, S. K. N., Buchpiguel, C. A., Coutinho, A. M., & Faria, D. D. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70449 · Cited by 2
Vaqué‐Alcázar, L., Videla, L., Benejam, B., Soriano, L. D. H., Barroeta, I., Fernandez, S., Rodríguez‐Baz, Í., Arriola‐Infante, J. E., Arranz, J., Maure‐Blesa, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70447 · Cited by 2
Self-citationNovel predictors of Alzheimer's disease in Down syndrome identified using machine learning
Rubenstein, E., Tewolde, S., Michals, A. L., Fortea, J., Jimenez, M. P., Skotko, B. G., Tripodis, Y., Weuve, J., & Rosellini, A. J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251385423 · Cited by 2
Self-citationDevelopment of Molecular Neuropathology in Down Syndrome across the Lifespan
Bhattacharyya, A., de la Torre-Ubieta, L., Zhu, Y., Head, E., Swarup, V., & Sousa, A. M. M. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1365-25.2025 · Cited by 3
Self-citationRao, N. R., Santiago-Marrero, I. G., DeGulis, O. A., Nomura, T., Goyal, K., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E., Dulewicz, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adp3984 · Cited by 7
Silva, J. A., Liou, J., Parikh, S., Edwards, N. C., Kofler, J., Ikonomovic, M. D., Lai, F., Rosas, H. D., Powell, D. K., Schmitt, F. A., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00062-2 · Cited by 3
Self-citationTramutola, A., Lanzillotta, C., Domenico, F. D., Barone, E., & Marzia Perluigi, A. (2026) · Antioxidants · doi:10.3390/antiox15040520 · Cited by 2
Meguid, N. A., Hemimi, M., Elpatrik, G., Fouad-Elhady, E. A., Dardir, A. A., & Ahmed, H. H. (2024) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01206-y · Cited by 2
Russell, J. K., Conley, A. C., Wilson, J. E., & NEWHOUSE, P. A. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_523 · Cited by 3
Krinsky‐McHale, S. J., Kovacs, C. M., Lee, J. H., Listwan, T. A., Pang, D. I., Schupf, N., Tycko, B., Zigman, W. B., & Silverman, W. P. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70076 · Cited by 2
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process
Cordeiro, A. M. T., Singulani, M. P., Talib, L. L., & Forlenza, O. V. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326291 · Cited by 2
Lioudyno, M., Sevrioukov, E. A., Olivarria, G. M., Hitchcock, L., Javonillo, D. I., Campos, S. M., Rivera, I., Wright, S. T., Head, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02895-2 · Cited by 3
Self-citationRole of Galangin for the Treatment of Alzheimer’s Disease: Journey So Far and Road Ahead
Sharma, P., Sharma, T., Bashir, B., andotra, N., Awasthi, A., Patel, P. V., Subramaniyan, V., Chellappan, D. K., Gupta, G., Vishwas, S., et al. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00669-6 · Cited by 2
Moreno, B. S., Zhang, L., Salaberry, A. C., Aranha, M. R., Moldenhauer, F., Brudfors, M., Ashburner, J., Nachev, P., de Asúa, D. R., & Strange, B. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70296 · Cited by 1
Object and action naming in adults and aged people with Down syndrome
Carvalho, C. L., da Conceição, A. D. S. G. G., Ramos, A. R., Sant’Ana, L. C. F. G., da Silva, M. D. F. R., Ribeiro, O. G., Forlenza, O. V., & Radanovic, M. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0272 · Cited by 2
Vázquez‐Oliver, A., Pérez‐García, S., Pizarro, N., Molina‐Porcel, L., de la Torre, R., Maldonado, R. J., & Ozaita, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.22.469296 · Cited by 2
von Scheibler, E. N. M. M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231114eb · Cited by 2
A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively StablePreprint
Liou, J., Lou, J. J., Nakagiri, J., Yong, W. H., Hom, C. L., Doran, E. W., Totoiu, M. O., Lott, I. T., Mapstone, M. E., Keator, D. B., et al. (2024) · medRxiv · doi:10.1101/2024.06.01.24308050 · Cited by 2
Self-citationSun, C., Thomas, R. W., Stringer, C. A., Galani, K., Ho, L., Sun, N., Renfro, A., Wright, S. T., Firenze, R. M., Tsai, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.17.719050 · Cited by 2
Self-citationLefter, N., Abdulan, I. M., Maștaleru, A., Leon, M., & Rusu, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195829 · Cited by 1
Reflecting on progress, envisioning the future for research in Down syndrome
Santoro, J. D., & Rafii, M. S. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00510-0 · Cited by 1
Self-citationKrutish, A., Kukurudz-Gorowski, R., Borlot, F., Frosk, P., Greenberg, C. R., & Mhanni, A. A. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1595298 · Cited by 1
The effect of music on endurance performance: study with females with Down syndrome
dos Santos, J. A. R., dos Santos, N. P. P., Boppre, G., Cardoso, V. D., & Corredeira, R. (2025) · Journal of Movement & Health · doi:10.5027/jmh-vol22-issue2(2025)art258 · Cited by 1
Fleming, V., Helsel, B. C., Ptomey, L. T., Handen, B. L., Krinsky‐McHale, S. J., Hom, C. L., Zammit, M. D., Minhas, D. S., Luo, W., Laymon, C. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70387 · Cited by 1
Self-citationPreliminary investigation of obstructive sleep apnea and Alzheimer’s disease in down syndrome
Yoon, D. M., Plante, D. T., Fleming, V., Handen, B. L., Lao, P. J., Peven, J. C., Christian, B. T., Okonkwo, O. C., Laymon, C. M., Ances, B. M., et al. (2025) · SLEEP Advances · doi:10.1093/sleepadvances/zpaf044 · Cited by 1
Self-citationAlzheimer's disease in Down syndrome: progress and promise
Ryan, N. S. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00276-5 · Cited by 1
Keller, P. C., & Sappok, T. (2025) · Journal of Intellectual Disability Research · doi:10.1111/jir.70016 · Cited by 1
Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sites
Ptomey, L. T., Hom, C. L., Wilkins, H., Doran, E. W., Wright, S. T., Hoang, D., Delehoy, B., Lott, I. T., Perales‐Puchalt, J., Helsel, B. C., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70612 · Cited by 1
Self-citationHardiman, S., Cousins, R., Ryan, A., Kennedy, M., Hagan, L., & Santos, F. H. (2025) · Journal of Applied Research in Intellectual Disabilities · doi:10.1111/jar.70120 · Cited by 1
Cross‐Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease
Abdelmoity, O., Wisch, J. K., Kennedy, J. T., Goyal, M. S., Vlassenko, A. G., Flores, S. E., Handen, B. L., Head, E., Keator, D. B., Rafii, M. S., et al. (2025) · Annals of Neurology · doi:10.1002/ana.78002 · Cited by 1
Self-citationAnticholinergics, executive function, and cognitive/behavioral changes in Down syndrome
Lee, N., McQuaid, G. A., Jiddou, H., McNulty, J., Grosman, H. E., Tucker, K. T., O’Brien, M., & Wallace, G. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70649 · Cited by 1
The joint association of obesity and physical activity on cognitive function in Down syndrome
Clina, J. G., Helsel, B. C., Hartley, S. L., Fleming, V., Handen, B. L., Christian, B., Head, E., Mapstone, M. E., Hom, C. L., Burns, J. M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251386474 · Cited by 1
Self-citationWagemann, O., Tesky, V. A., Schall, A., Nübling, G., Wlasich, E., Hüer, T., Walendzik, A., Weitzel, M., Giebel, G. D., Raszke, P., et al. (2025) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2708-3648 · Cited by 1
Identification of RALY as a novel regulator of DSCR1 transcription
Park, J., Choi, C., Kim, H., & Roh, J. H. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153263 · Cited by 1
Unmasking the hidden catalyst: How infections trigger Alzheimer's disease
Fülöp, T., Cohen, A. A., Frost, E. H., Lévesque, S., Khalil, A., Rodrigues, S., Desroches, M., Alami, M., Berrougui, H., Ramassamy, C., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415571 · Cited by 2
Factors impacting survival in individuals with Down syndrome‐associated Alzheimer's disease
Benejam, B., McCarron, M., Carmona‐Iragui, M., Dunne, P., Maure‐Blesa, L., Altuna, M., Arranz, J., Barroeta, I., Bejanin, A., Soriano, L. D. H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71156 · Cited by 2
Self-citationHibbs, C., Hendriks, S., Muris, J. W. M., Leijenaar, R. T. H., Horstkötter, D., Köhler, S., & de Vugt, M. E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261451197 · Cited by 1
CSF and plasma tau biomarkers in the Down syndrome–Alzheimer’s disease continuum
Arranz, J., Lantero‐Rodriguez, J., Braun-Wohlfahrt, L. S., Vaqué‐Alcázar, L., Rodríguez‐Baz, Í., Kac, P. R., Arslan, B., Maure‐Blesa, L., Pertierra, L., Videla, L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106370 · Cited by 2
Self-citationda Silva, A. M. P., Tudella, G. C. N., Lee, A. M., Santos, D. H., Cukiert, C. M., & Perry, G. L. (2026) · Seizure · doi:10.1016/j.seizure.2026.08.023 · Cited by 1
Harris, M. C., Brown, D. J., Vyas, P., Lewis, J. E., & Connor, B. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-35992-7_42 · Cited by 1
Down Syndrome—Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort
Altuna, M., Estanga, A., Garrido, A., Saldias, J., Cañada, M., Echeverria, M., Larrea, J. Á., Ayo, P., Fiz, A., Muñoz, M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041139 · Cited by 1
Baksh, R. A., Strydom, A., Carter, B., Carrière, I., & Ritchie, K. A. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12563
Insights into the progression of genetic Alzheimer's disease from tau PET
Nordberg, A. K. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00124-8 · Cited by 1
Incorporating advance care planning in dementia care
Giotas, D., & Dening, K. H. (2024) · Nursing Older People · doi:10.7748/nop.2024.e1463 · Cited by 1
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome
Nakashima, K., Imai, T., Shiraishi, A., Unose, R., Goto, H., Nagatomo, Y., Kojima‐Ishii, K., Mushimoto, Y., Nishiyama, K., Yamamura, K., et al. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae048 · Cited by 1
Spatial mapping of Alzheimer’s disease across genetic subtypes
Nott, A., & Holtman, I. R. (2024) · Nature Genetics · doi:10.1038/s41588-024-01895-4 · Cited by 1
Wagemann, O., Brendel, M., Franzmeier, N., Nübling, G., Gnörich, J. S., Zaganjori, M., Prix, C., Stockbauer, A., Wlasich, E., Loosli, S. V., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505999 · Cited by 1
Adamo, M., Gayer, M., Jacobs, A., Raynaud, Q., Sebbah, R., Domenicantonio, G. D., Latypova, A., Vionnet, N., Kherif, F., Lutti, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf117 · Cited by 1
Boer, P. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1595710 · Cited by 1
What are the Risk Factors for Alzheimer's Disease?
(2022) · DHR Proceedings · doi:10.47488/dhrp.v2is2.60 · Cited by 1
Head, E., & Zetterberg, H. (2022) · Annals of Neurology · doi:10.1002/ana.26414 · Cited by 1
Self-citationWu, Y., Mumford, P., Noy, S., Cleverley, K., Mrzyglod, A., Luo, D., van Dalen, F. J., Verdoes, M., Fisher, E., & Wiseman, F. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545700 · Cited by 1
Bartholomew, S. K., Turk, J., Winslow, W., Foley, C., Shaw, A. Y., Rokey, S., Tallino, S., Judd, J. M., Beach, T. G., Serrano, G. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700091 · Cited by 1
Nordbeck, A. J., Martá‐Ariza, M., Ek Olofsson, H., Kanshin, E., Ueberheide, B., Jones, K., Sanford, B., Hamlett, E. D., Head, E., Mufson, E. J., et al. (2026) · Alzheimer's & Dementia · doi:10.1002/alz.71776
“7,9,50 While previous work focused on proteomic differences associated with amyloid pathology in DS, 51 the present study provides a potential linkbetweenspatiallyresolvedmTOR/INSregulatoryanddownstream protein-level alterations in DS-AD.”
InfluentialSelf-citationMontoliu‐Gaya, L., Alcolea, D. A., Ashton, N. J., Pegueroles, J., Levin, J., Carmona‐Iragui, M., Lantero‐Rodriguez, J., Karikari, T. K., Barroeta, I., Kac, P. R., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4077901
Self-citationBarišić, A., & Vraneković, J. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02280-z
Genetica della malattia di Alzheimer
Wallon, D., & Nicolas, G. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)47093-0
Who is seen by a community learning disability psychology service? Learning and future directions
Atkin, C., Laute, V., & Collins, K. (2022) · FPID Bulletin The Bulletin of the Faculty for People with Intellectual Disabilities · doi:10.53841/bpsfpid.2022.20.3.7
Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00018-3
Biomarcadores amiloidogênicos na síndrome de Down
Bram, J. M. D. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-20092023-163847
Alzheimer-en gaixotasuna Down-en sindromearen barnean
Altuna, M., Estanga, A., Clerigué, M., de Arriba, M., & Saldias, J. (2023) · Osagaiz osasun-zientzien aldizkaria · doi:10.26876/osagaiz.1.2023.478
High-resolution structures of amyloid-β and tau aggregates in individuals with Down syndrome
(2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01254-1
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151181
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151178
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151166
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151172
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151169
Ione, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-55440-7_1
Jensen, K. M., Bulova, P. D., & Santoro, S. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-54281-7_30
Kasai, T., Shinomoto, M., Kitani‐Morii, F., Ohmichi, T., Fujino, Y., Kondo, M., Terada, N., Tatebe, H., Tokuda, T., & Mizuno, T. (2024) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001976
Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndromePreprint
Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T. J., Laymon, C. M., Tudorascu, D., Cohen, A. D., Zaman, S. H., Ances, B. M., et al. (2024) · medRxiv · doi:10.1101/2024.08.08.24311702
Self-citationNeuropsychologie du vieillissement normal et des syndromes démentiels
Gil, R. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78570-2.00023-x · Cited by 1
Hospitalization of patients with Down syndrome in acute care hospitals in Japan
Yasunami, K., Matsugaki, R., Muramatsu, K., & Matsuda, S. (2024) · Journal of General and Family Medicine · doi:10.1002/jgf2.746
Guimarães, M. C. M., de Cerqueira, A. B. F., Santos, B. C. D. O., Custódio, B. G. R., Meneses, B. D. M., de Brito, C. V., Silva, G. T. D. S., Noronha, G. R. M., Queiroz, H. A., Noronha, J. F. M., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594972405119
Mecanismos fisiopatológicos relacionados à Doença de Alzheimer em pacientes com Síndrome de Down
ALVARENGA, C. D. B., Gomes, L. D. O. S., & Rosa, Á. N. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n10-051
Palumbo, M. L., Santoro, S. L., & Howe, Y. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-76269-7_4
Jandy, M., Hu, H., Liu, Y., & Bhattacharyya, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-78611-2_7
Schworer, E. K., Handen, B. L., Krinsky‐McHale, S. J., Hom, C. L., Clare, I. C. H., Harp, J. P., Pulsifer, M. B., Mapstone, M. E., Head, E., Christian, B., et al. (2025) · Journal of Intellectual Disability Research · doi:10.1111/jir.13237
Self-citationMartínez, J. M. B., Bernardo, M. D. C. O., Aguirre, F. T., Díaz, F. M., & Cerdá, R. F.-D. (2025) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2024.09.005
Plasma biomarkers for diagnosis and prognosis in Down syndrome-related Alzheimer's disease
Teunissen, C. E., & Duits, F. H. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00203-0
Brain metabolic and behavioral alterations in a Down syndrome model
de Souza, L. E., Righini, C. M., Mantovani, D. B. D. A., Silva, M. P., Lazzarotto, G., Limberger, C., Buchpiguel, C. A., Zimmer, E. R., Real, C. C., Spelta, L. E. W., et al. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.109052
Implications of Down Syndrome on Dental Management
Hewitt-Dean, J. (2025) · Dental Update · doi:10.12968/denu.2025.52.7.494
Metadata
- Authors
- Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- University of Cambridge (GB)
- University of Wisconsin–Madison (US)
- University of Southern California (US)
- University of California, Irvine (US)
- Corresponding author
- Fortea, Juan
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 20
- Issue
- 11
- Pages
- 930-942
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC9387748
- OpenAlex
- W3205749467
- Cited by
- 357
- References
- 125
- Citations by year
- 2026: 66 · 2025: 121 · 2024: 83 · 2023: 48 · 2022: 36 · 2021: 3
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Generalitat de Catalunya
- Instituto de Salud Carlos III
- National Institutes of Health
- Roche España (BFF17-008, P30AG066519, PI18/00335, R01HD064993, U19AG068054)
- European Commission
- Fondation Jérôme Lejeune (1913, 2019B)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01AG031110, U01 AG051412, U01AG051406, U54 HD090256)
- Global Brain Health Institute (GBHI_ALZ-18-543740)
- European Regional Development Fund
- National Institute on Aging (1R01AG056850 - 01A1, R01AG061566, R21AG056974)
- Generalitat of Catalonia Department of Health (SLT006/17/00119)
- Fundació Víctor Grífols i Lucas
- Alzheimer's Association
- Societat Catalana de Pneumologia
- Fundació la Marató de TV3 (20141210)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Down syndrome, Alzheimer's disease, early-onset dementia, dementia diagnosis, fluid biomarkers, neuroimaging biomarkers, intellectual disability, Alzheimer's disease prevention, disease-modifying therapy
- MeSH terms
- Adult, Alzheimer Disease, Down Syndrome, Humans, Intellectual Disability, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
